Streamline Health Solutions, Inc. Stock

Equities

STRM

US86323X1063

Healthcare Facilities & Services

Market Closed - Nasdaq 04:30:00 2024-05-10 pm EDT 5-day change 1st Jan Change
0.3337 USD -0.57% Intraday chart for Streamline Health Solutions, Inc. +14.67% -21.48%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2025 * 19.99M Sales 2026 * 20.83M Capitalization 21.15M
Net income 2025 * -7M Net income 2026 * -3M EV / Sales 2025 * 1.06 x
Net cash position 2025 * - Net cash position 2026 * - EV / Sales 2026 * 1.02 x
P/E ratio 2025 *
-3.03 x
P/E ratio 2026 *
-5.56 x
Employees 112
Yield 2025 *
-
Yield 2026 *
-
Free-Float 73.89%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Streamline Health Solutions, Inc., Q4 2024 Earnings Call, Apr 30, 2024
Streamline Health Solutions, Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024 CI
Streamline Health Solutions, Inc. Reports Earnings Results for the Full Year Ended January 31, 2024 CI
Streamline Health Solutions, Inc. Expands eValuator?? Footprint with Existing Client CI
Streamline Health Solutions, Inc. Signs Second Enterprise Client CI
Streamline Health Solutions, Inc. Appoints New Directors CI
Streamline Health Solutions, Inc. announced that it has received $4.4 million in funding CI
Streamline Health Solutions, Inc. announced that it expects to receive $4.4 million in funding CI
Streamline Health Solutions, Inc. Expands Agreement with Existing eValuator Client to Add RevID CI
Transcript : Streamline Health Solutions, Inc., Q3 2024 Earnings Call, Dec 14, 2023
Streamline Health Solutions, Inc. Announces Impairment Charges for the Three Months Ended October 31, 2023 CI
Streamline Health Announces Signing of New RevID Contract with 2,300-Bed Health System CI
Streamline Health Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023 CI
Pennsylvania-Based Health System Expands Relationship with Streamline Health Evaluator Pro-Fee Module CI
Streamline Health Solutions, Inc. Announces New eValuator Contract with Florida-Based Academic Medical Center CI
More news

Latest transcript on Streamline Health Solutions, Inc.

1 day-0.57%
1 week+14.67%
Current month+11.61%
1 month-16.57%
3 months-38.30%
6 months-5.47%
Current year-21.48%
More quotes
1 week
0.29
Extreme 0.29
0.35
1 month
0.24
Extreme 0.24
0.44
Current year
0.24
Extreme 0.24
0.64
1 year
0.21
Extreme 0.213
1.70
3 years
0.21
Extreme 0.213
2.35
5 years
0.21
Extreme 0.213
3.86
10 years
0.21
Extreme 0.213
5.77
More quotes
Managers TitleAgeSince
Chief Executive Officer 35 12-12-31
Director of Finance/CFO 48 20-06-30
Chairman 52 18-08-06
Members of the board TitleAgeSince
Director/Board Member 50 19-12-09
Director/Board Member 50 Feb. 06
Director/Board Member 51 05-04-30
More insiders
Date Price Change Volume
24-05-10 0.3337 -0.57% 27,176
24-05-09 0.3356 -2.39% 6,253
24-05-08 0.3438 +4.18% 49,230
24-05-07 0.33 0.00% 53,722
24-05-06 0.33 +13.40% 80,815

Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT

More quotes
Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The Company sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. It offers an array of professional services, including system implementation.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3337 USD
Average target price
1.5 USD
Spread / Average Target
+349.51%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW